Introduction
Sensory nerves containing calcitonin gene-related peptide (CGRP) and other neurotransmitters are expressed throughout the cardiovascular system and can regulate vascular tone. [1] [2] [3] [4] [5] They are assumed to reside exclusively/predominantly in the adventitia, the outermost layer of blood vessels, which includes elastic and collagen fibres. The rat isolated mesenteric arterial bed preparation has been widely used to define our understanding of sensory neurotransmission in blood vessels; [6] [7] [8] [9] [10] [11] [12] in this preparation electrical field stimulation (EFS) elicits pronounced neurogenic vasorelaxation due to activation of sensory nerves and release of CGRP; it is noteworthy that the mesenteric arterial bed is extensively covered in perivascular adipose tissue (PVAT). In contrast, attempts to demonstrate neurogenic relaxation to EFS in rat isolated mesenteric arteries have been unsuccessful; whilst rat isolated mesenteric arteries do relax to EFS, this is not thought to be a sensory nerve generated response and rather is myogenic or dependent on an intact endothelium. [13] [14] [15] Moreover, there are surprisingly few reports of sensory neurogenic relaxation in other isolated arteries. Here, we present evidence that this is due to the normal process of removing PVAT from artery segments before experimentation, a process that is not normally applied to the whole mesenteric arterial bed preparation.
In this study, we tested the hypothesis that sensory nerves are expressed in PVAT. PVAT surrounds most blood vessels except for the cerebral vasculature and microvasculature 16 and is attracting increasing interest as a regulator of vascular function and because of evidence for its involvement in dysfunctional arterial contractility in pathophysiological conditions. [17] [18] [19] [20] [21] Sensory nerves are present in white adipose tissue (WAT) [22] [23] [24] [25] and brown adipose tissue, 26, 27 but their expression and roles in PVAT have not previously been reported. PVAT is a source of adipokines and other vasoactive compounds, but the relationship between these compounds and sensory nerves is also poorly understood. Evidence for interactions between leptin and sensory nerves was shown in WAT, where leptin secreted from the adipocytes increased the activity of sensory nerves innervating the tissue. 25 In the present study, we tested the hypothesis that sensory nerves in PVAT have a fundamental role in artery vasodilatation and adipokine release, and that cross-talk may be disrupted under conditions of reduced oxygenation, such as might arise due to adipose tissue expansion in obesity. We provide evidence that the expression and role of sensory nerves in the control of blood vessel contractility has been underestimated, with implications for our understanding of cardiovascular function under physiological conditions and in disease.
Methods

Rat tissue preparation
All experimental procedures were approved by the Animal Care and Use Committee of University of Nottingham, United Kingdom. Male Wistar rats weighing 180-220 g were killed by stunning and exsanguination. The mesenteric arterial beds were isolated and dissected as described previously. 6, [10] [11] [12] Mesenteric arteries and mesenteric arterial beds were prepared in two conditions, either as PVAT intact (PVATþ) or as PVAT denuded (PVAT-). PVAT removal from mesenteric arterial beds was carried out as described previously. 28 PVAT was carefully removed from mesenteric arteries/arterial beds with fine scissors under a dissecting microscope paying attention not to damage the adventitial layer.
Mesenteric arterial bed perfusion
The mesenteric arterial beds were perfused as described previously. 6, [10] [11] [12] Briefly, the superior mesenteric artery was cannulated and the mesenteric arterial bed was separated from the intestine by cutting close to the intestinal wall. Only four main arterial branches from the superior mesenteric trunk running to the terminal ileum were perfused while other branches of the superior mesenteric artery were tied off. The preparation was contained within a humid chamber and perfused with Krebs-Henseleit solution at a constant flow rate of 5 mL min -1 using a peristaltic pump (model 7554-30; Cole-Parmer Instrument Co., Chicago, U.S.A.). The Krebs solution was gassed with 95% O 2 and 5% CO 2 and maintained at 37 C.
Responses elicited by EFS (0.5-12 Hz, 60 V, 0.1 ms, 30 s) were investigated in the presence or absence of PVAT. Exogenous CGRP (1.5 Â 10 -13 to 1.5 Â 10 -10 moles) was added as bolus doses.
Wire myography
Fine dissection was used to isolate superior mesenteric and secondorder mesenteric arteries of the mesenteric arterial bed using a dissecting microscope. Arteries were cut into ring segments, mounted on fine wires, and placed between the plastic jaws of a dual and multi-channel wire myograph (Danish Myo Technology, Arhus, Denmark). The isometric tension recordings were carried out as described previously. 29 Segments were equilibrated in Krebs solution at 37 C, gassed with 95% O 2 and 5% CO 2 . Tensions of 1 g and 0.5 g were applied to superior mesenteric and second-order mesenteric arteries, respectively, in the presence of guanethidine (5 mM) and methoxamine (1-10 mM) (to block sympathetic neurotransmission and pre-constrict the preparations, respectively). EFS at 0.5-12 Hz, 40 and 60 V, 0.05 and 0.1 ms, 30 s was carried out to investigate nerve-mediated vasorelaxant responses. Finally tetrodotoxin (1 mM), a neurotoxin which acts by blocking sodium channels, was added after a stable tone was achieved and then responses to EFS were repeated. In separate experiments leptin (0.1 pM) was added after stable tone to methoxamine had been achieved and, after 5 min, cumulative relaxation responses to CGRP were constructed.
Immunofluorescence staining
Superior mesenteric arteries, first-order mesenteric arteries, secondorder mesenteric arteries, and third-order mesenteric arteries were fixed in 4% (w/v) paraformaldehyde for 3 h. Briefly, samples were sectioned on a cryostat at 40 mm (Leica model CM1900, Heidelberg, Germany). In some of PVATþ (double staining) preparations, fat from half of the vessel was removed and immunofluorescence staining procedures were conducted as described below with omission of the cutting step; this procedure was conducted with the aim of obtaining more nerve profiles. 
Enzyme immunoassay (EIA)
CGRP release was quantified using EIA as described previously. 12 PVAT dissected from segments of mesenteric arteries (superior mesenteric and second-order mesenteric arteries) was incubated in Krebs solution with and without capsaicin (10 mM) at 37 C, for 15 min. The solutions were then assayed for CGRP content using rat CGRP EIA kit (SPI-BIO, Bertin Pharma, Montigny-le-Brentonneux, France). CGRP in each sample was extracted using OasisV R HLB Extraction cartridges (Waters, Massachusetts, USA) in acidic conditions. Extracts were incubated for 18 h in 96-CGRP monoclonal antibody anticholinesterase enzyme (AChE) coated wells. The concentration of rat CGRP was determined by measuring the enzymatic activity of the AChE using Ellman's reagent. The intensity of the colour changes, determined by spectrophotometry, is proportional to the concentration of rat CGRP.
Multiplex immunoassay
Mesenteric arterial beds with and without PVAT were perfused at 3 mL/ min with Krebs-Henseleit solution containing guanethidine (5 mM) and methoxamine (1-5 mM), to inhibit sympathetic neurotransmission and pre-contract the preparations, respectively. [6] [7] [8] [9] [10] [11] [12] 
Materials
Methoxamine hydrochloride and capsaicin were purchased from SigmaAldrich (Dorset, U.K.). Guanethidine monosulphate (Ismelin V R ) was purchased from Amdipharm Mercury (London, U.K.). Tetrodotoxin and CGRP were purchased from Tocris Bioscience (Bristol, U.K.). Leptin was from Source Bioscience UK Ltd. Capsaicin was dissolved in ethanol (stock of 10 mM) while other drugs were dissolved in distilled water.
Statistical Analyses
Relaxant responses of the mesenteric arterial beds and mesenteric arteries were expressed as percentage decrease in pressure (mmHg) or tension (g) respectively, against the methoxamine-induced raised tone. Data are reported as means ± SEM. Two-way ANOVA with Bonferroni or Sidak's post hoc test was conducted for EFS data, EIA assay of CGRP release, multiplex assay of adipokine release, and CGRP relaxations in mesenteric arteries. Locally Weighted Scatter-plot Smoother (LOWESS) was carried out to determine interpolated X values from unpaired Y values in EIA experiments. All analyses were carried out using GraphPad Prism (Version 6, GraphPad Software, California, USA). P-values of <0.05 were considered statistically significant. n indicates number of rats.
Results
Removal of PVAT abolishes sensory vasodilatation responses in the perfused mesenteric arterial bed
The rat mesenteric arterial bed is a preparation with extensive PVAT and a pronounced sensory neurogenic vasorelaxant response.
6-12 EFS (0.5-12 Hz, 60 V, 0.1 ms and 30 s) of perfused mesenteric arterial beds in the presence of guanethidine and methoxamine (to block sympathetic neurotransmission and pre-constrict the preparations respectively) elicited frequency dependent vasodilatation in preparations with intact PVAT (PVATþ) ( Figure 1A ). We and others have shown that these responses are abolished by capsaicin and tetrodotoxin treatment identifying an involvement of capsaicin-sensitive sensory nerves. 6, 7, 30 We investigated the effect of removing the PVAT on the sensory neurogenic vasorelaxant response. Neurogenic vasodilatation was virtually abolished in preparations in which PVAT had been removed by dissection (e.g. at 12 Hz: PVATþ, 85 ± 3% vs. PVAT-, 8 ± 2%; n = 4) ( Figure 1B) .
To examine the integrity of vessels in both PVATþ and PVAT-preparations, bolus injection of exogenous CGRP (1.5 Â 10 -13 to 1.5 Â 10 -10 moles) was carried out. There was no difference in vasorelaxant responses to CGRP between the preparations ( Figure 1C) showing that the ability of the smooth muscle to relax was similar between the preparations with and without PVAT.
Electrically-evoked neurogenic vasodilatation in isolated mesenteric arteries under isometric tension reveals the role of PVAT and influence of vessel size
To further investigate the possible contribution of sensory nerves in PVAT to the control of vasomotor tone, isometric tension recording was conducted in rat isolated mesenteric arteries with and without PVAT. Responses to EFS were investigated in methoxaminepreconstricted artery segments in the presence of guanethidine (5 mM) to block sympathetic neurotransmission. In second-order mesenteric artery segments with PVAT, EFS elicited frequency-dependent relaxation which was greatly reduced in the presence of tetrodotoxin (e.g. at 12 Hz: PVATþ, 67±14% vs. PVATþ with tetrodotoxin, 12 ±7%) (P < 0.001, n = 6) ( Figure 2A -C). In superior mesenteric arteries with PVAT, relaxation responses to EFS were small (e.g. at 12 Hz: PVATþ, 5 ± 3%) and were abolished in the presence of tetrodotoxin (n = 6) ( Figure 2D ). Thus, in the presence of PVAT, neurogenic relaxation responses to EFS were observed, which were greater in second-order mesenteric arteries compared to superior mesenteric arteries (compare Figure 2C and 2D).
In second-order mesenteric arteries without PVAT, the effect of EFS (0.5-12 Hz, 60 V, 0.1 ms, 30 s) was investigated in artery segments from nine rats: in two of the preparations we observed minimal vasodilatation (<5% relaxation at 8 and 12 Hz); in seven other preparations a vasodilator response was observed, but these responses were tetrodotoxinresistant, as reported by others. [13] [14] [15] The stimulation parameters used were reduced, to 0.5-12 Hz, 40 V, 0.05 ms, 30 s, in an attempt to identify a tetrodotoxin-sensitive neurogenic response; under these conditions only small relaxation responses were observed in the second-order mesenteric arteries without PVAT, and these were blocked by tetrodotoxin (e.g. at 12 Hz, PVAT-, 5 ± 4%, PVAT-with tetrodotoxin, 0 ± 0%, n = 4). In superior mesenteric arteries without PVAT, no relaxation responses to EFS (0.5-12 Hz, 60 V, 0.1 ms, 30 s) were observed (e.g. at 12 Hz: PVAT-, 0 ± 0%; n = 6). These data identify the essential requirement of sensory nerves in PVAT to vasorelaxant control of rat small mesenteric arteries. The nerves are not parasympathetic vasodilator nerves, since neurogenic relaxations in the rat mesenteric arterial bed are unaffected by atropine (muscarinic antagonist). (PVATþ) ( Figure 3D-F) . Immunoreactivity for CGRP was observed both on the surface of the vessels ( Figure 3A and 3B) and within the PVAT ( Figure 3D and 3E). Fibre-like structures were observed and some of them appeared to have neuronal somata ( Figure 3A and 3B).
To confirm the expression of CGRP-containing nerves within PVAT, a co-localization protocol was employed on PVAT of the mesenteric arteries. Superior mesenteric and second-order mesenteric artery segments with PVAT intact were co-treated with anti-CGRP (red staining) and anti-PGP9.5 (green staining). Intense double immunoreactivity was observed as yellow staining, and showed the presence of nerves and neuronal somata as shown in Figure 4 . In the absence of anti-CGRP nerve antibody (negative control), no immunoreactivity was visualized in the artery segments as shown in Figure 3 (C, F) and Figure 4 (E, J).
EIA shows CGRP expression in PVATof mesenteric arteries
To further examine whether the CGRP is associated with sensory nerves in PVAT, dissected PVAT (isolated from superior mesenteric and second-order mesenteric arteries) was incubated in Krebs solution with and without capsaicin (10 mM, 15 min), and then EIA was carried out on samples of the supernatant to measure the amount of CGRP released. In dissected fat isolated from the second-order mesenteric artery, the CGRP level was more than 100% greater after exposure to capsaicin (8.4 ± 1 pg/mL/cm; n = 4) than in the absence of capsaicin (3.6 ± 0.4; n = 4) ( Figure 5 ). CGRP levels in the supernatant of dissected fat isolated from superior mesenteric arteries were similar with (2.6 ± 0.5 pg/mL/cm; n = 4) and without (2.6 ± 0.9 pg/mL/cm; n = 4) capsaicin treatment ( Figure 5 ).
Interactions between sensory nerves and PVAT-derived mediators
Given the above evidence for expression of sensory nerves within PVAT, we investigated whether their activation could affect adipokine release. In mesenteric arterial beds pre-contracted with methoxamine (1-5 mM) and in the presence of guanethidine (5 mM), levels of leptin collected in the perfusate were greater in PVATþ preparations than in PVAT-preparations (15.6 ± 2.6 pg/mL; n = 10 vs. 1.9 ± 0.8 pg/mL; n = 6) (P < 0.05, ANOVA) ( Figure 6A) . Moreover, in the presence of PVAT, leptin levels measured in the perfusate collected during EFS of sensory nerves were significantly enhanced (28.1 ± 4.4 pg/mL, n = 10) (P < 0.05, ANOVA) ( Figure 6A ). Mesenteric arterial beds with intact PVAT released a significantly greater amount of adiponectin into the perfusate than PVAT-preparations (160 ± 33 ng/mL; n = 11 vs. 2 ± 0.8 ng/mL; n = 5, respectively) (P < 0.01, ANOVA) ( Figure 6B) . However, adiponectin release in PVATþ preparations was similar during EFS (8 Hz, 60 V, 0.1 ms, 30 s) induced sensory neurogenic activation (129 ± 25 ng/mL; n = 11) as under control conditions in the absence of EFS ( Figure 6B ).
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-11 . In PVAT-, the EFS vasodilator response was attenuated (n = 4). C, There was no difference between preparations with and without PVAT with regard to relaxation responses to bolus doses of calcitonin gene-related peptide (CGRP) (P > 0.05, n = 5). ***P < 0.001, ****P < 0.0001, PVATþ vs. PVAT-. Figure 4 Co-localization of CGRP and PGP 9.5 (neuronal marker) within PVAT of rat mesenteric arteries. Double staining for calcitonin gene-related peptide (CGRP) and PGP 9.5 within perivascular adipose tissue (PVAT) of rat mesenteric arteries: Anti-CGRP staining in PVAT of superior mesenteric artery (red) (A), anti-PGP 9.5 staining in PVAT of superior mesenteric artery (green) (B), merged image shows some neurons co-expressing CGRP and PGP 9.5 in PVAT of superior mesenteric artery (yellow) (C). 3-dimensional merged image showing some neurons co-expressing CGRP and PGP 9.5 marker in PVAT region of superior mesenteric artery (D). In the absence of anti-CGRP and anti-PGP 9.5 antibodies (negative control) in PVAT of superior mesenteric artery, no staining was observed (E). Anti-CGRP staining in PVAT of second-order mesenteric artery (red) (F), anti-PGP 9.5 staining in PVAT of second-order mesenteric artery (green) (G), merged image shows some neurons co-expressing CGRP and PGP 9.5 in PVAT of second-order mesenteric artery (yellow) (H). 3-dimensional image of some neurons co-expressing CGRP and PGP 9.5 in PVAT of second-order mesenteric artery (I).
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In the absence of anti-CGRP and anti-PGP 9.5 antibodies (negative control) in PVAT of second-order mesenteric artery, no staining was observed (J). Deoxyribonucleic acid (DNA) was counterstained with DAPI (blue). Arrows indicate CGRP and PGP 9.5 double labelled: a = nerve, b =cell body/neuronal somata. Scale bars for A-D, F, G, and H = 23 mm, I = 16.46 mm and E and J = 50 mm (n = 6 preparations from two rats). 
.6 Effects of reduced oxygen level on the interactions between sensory nerves and PVAT-derived mediators
The effects of oxygen level on perfusate leptin and adiponectin levels were investigated in mesenteric arterial beds with intact PVAT pre-contracted with methoxamine (1-5 mM), in the presence of guanethidine (5 mM) to block sympathetic neurotransmission; we hypothesized that reduced oxygen, such as can occur during adipocyte expansion, would alter adipokine release and consequently the interactions between sensory nerves and adipocytes. The raised tone of the preparations gassed with standard oxygen was decreased with a low oxygen supply (48 ± 9 mmHg vs. 14 ± 7 mmHg respectively; n = 8), so responses to EFS could not be meaningfully quantified. EFS had no significant effect on leptin release under conditions of reduced oxygenation (standard oxygen, 28.1 ± 4.4 pg/mL; n = 10 vs. low oxygen, 1.8 ± 0.4 pg/mL; n = 8) ( Figure 7A) . In both standard oxygen and low oxygen, adiponectin was detected in the perfusate of PVATþ mesenteric arterial beds ( Figure 7B ). Low oxygen significantly decreased the level of adiponectin collected in the perfusate at basal conditions (standard oxygen, 160.3 ± 32.9 ng/mL; n = 11 vs. low oxygen, 57.1 ± 15.2 ng/mL; n = 7) and during EFS (standard oxygen, 129 ± 24.5 ng/ mL; n = 11 vs. low oxygen, 33.3 ± 8.8 ng/mL; n = 9) (P < 0.05, ANOVA) ( Figure 7B ). Under standard oxygen conditions IL-6 was not detected in the perfusate of mesenteric arterial bed preparations, however, levels of IL-6 were significantly enhanced in low oxygen conditions ( Figure 7C ).
Leptin augments relaxation responses to CGRP in rat mesenteric arteries
The effect of leptin on CGRP responses was investigated to determine whether reciprocal interactions exist between sensory nerves and 
PVAT. CGRP elicited concentration-dependent relaxations in the rat
second-order mesenteric artery segments and these were augmented in the presence of leptin (0.1 pM) (n = 6) (P < 0.05, ANOVA). LogEC 50 values were: control -8.55 ± 0.25 (n = 6) and in the presence of leptin -8.87 ± 0.16 (n = 6) (see Supplementary material online, Figure S1 ). At this concentration (0.1 pM) leptin had no effect on the tone of the rat second-order mesenteric artery.
Discussion
The present study provides the first evidence for the distribution of sensory nerves in PVAT in any species, and shows that sensory nerves in PVAT play a direct role in vasoregulation of rat mesenteric arteries. This study is also the first that examines the direct effect of sensory nerve stimulation on levels of PVAT-derived mediator release. Main novel findings in this study are: (i) the immunofluorescence and EIA studies revealed that sensory nerves are expressed in PVAT; (ii) the isometric tension experiments of isolated superior mesenteric and second-order mesenteric arteries indicated that PVAT enhances neurogenic vasorelaxation, and this was greater in smaller arteries (second-order mesenteric arteries) compared to conduit arteries (superior mesenteric artery); (iii) the perfusion experiments showed that the absence of PVAT greatly attenuates EFS-evoked neurogenic vasorelaxation in the rat mesenteric arterial bed; (iv) sensory nerve activation stimulates leptin release in the presence of PVAT and this interaction was lost with PVAT removal and under conditions of reduced oxygenation; and (v) exogenous leptin augments CGRP-mediated vasorelaxation. A diagrammatic summary of some of the key findings is shown in Figure 8 .
Responses to EFS in isolated mesenteric arteries and perfused mesenteric arterial beds in the presence and absence of PVAT
The rat perfused mesenteric arterial bed preparation has been widely used to investigate sensory neurotransmission since EFS of the sensory nerves elicits robust vasorelaxant responses; it is a vascular preparation that is extensively covered in PVAT, although this is never specifically mentioned by users of the preparation. [6] [7] [8] [9] [10] [11] [12] For the first time, we investigated the effect of PVAT removal on the sensory neurogenic vasorelaxant response in the mesenteric arterial bed. EFS responses in rat perfused mesenteric arterial beds were greatly attenuated in preparations in which PVAT had been removed, consistent with the concept that the presence of PVAT enhances neurogenic vasodilatation. There are a number of possibilities that may contribute to this observation. The simplest explanation is that sensory nerves are expressed within PVAT and directly contribute to neurogenic vasodilatation of the mesenteric arterial bed, in line with the immunostaining and EIA evidence for the expression of CGRP-containing nerves in PVAT. However, we also present evidence for a selective release of leptin from PVAT concomitant with electrical stimulation of sensory nerves (discussed below), thus CGRP and/or other neurotransmitters released from sensory nerves may also act at adipocytes to release adipokines, which then act to enhance CGRP function and/or release.
In isometric tension experiments in methoxamine-preconstricted second-order mesenteric artery rings with PVAT intact, in the presence of guanethidine to block sympathetic neurotransmission, EFS elicited frequency-dependent vasodilatation. Tetrodotoxin almost abolished the Figure 7 The effect of oxygen level on mediators release during electrically-evoked neurogenic vasorelaxation in rat mesenteric arterial bed preparations with perivascular adipose tissue (PVATþ). Preparations were submaximally pre-contracted with methoxamine, guanethidine (5 mM) was present to block sympathetic neurotransmission, and electrical field stimulation (EFS; 8 Hz, 60 V, 0.1 ms, 30 s) was applied. A, The leptin level was reduced in conditions of low oxygen level (gassing with 95% N 2 5% CO 2 ) compared to standard oxygen levels (gassing with 95% O 2 5% CO 2 ) (n = 7-10). B, The level of adiponectin collected in the perfusate was also greater in standard oxygenation (n = 7-11). C, The IL-6 level was increased in a reduced oxygen level compared to a standard oxygen level in both basal conditions and during EFS (n = 3-7). *P < 0.05, **P < 0.01, ****P < 0.0001; ANOVA with Bonferroni post test.
EFS responses, which indicates that the responses were neurogenic. In contrast, responses to EFS in second-order mesenteric artery rings without PVAT were either very small or were not blocked by tetrodotoxin, as reported by others in rat isolated mesenteric arteries and in other arteries from different species. [13] [14] [15] These data identify fundamental differences in the vasorelaxant responsiveness of mesenteric arteries to EFS depending on the absence or presence of PVAT, where the presence of PVAT enhances neurogenic vasorelaxation. Classically, artery ring preparations are prepared for pharmacological investigation with PVAT removed, thus the present study may explain why there are so few reports of sensory neurogenic relaxations in isolated vessel preparations. In vessels with PVAT, neurogenic relaxation in second-order mesenteric arteries was much larger than in the superior mesenteric artery, suggesting that neurogenic vasorelaxation is dominant in smaller or resistance arteries compared to conduit arteries, in line with evidence that smaller arteries are more densely innervated than conduit arteries. 31 Given the crucial role of small arteries, these data indicate for the first time an important contribution of sensory nerves in PVAT to neurogenic control of blood vessel tone which could modulate vascular resistance and blood pressure.
The absence of PVAT had a more pronounced effect on sensory neurogenic relaxation than expected given that the immunofluorescence staining showed that sensory nerves densely innervate blood vessels in all orders (superior mesenteric, first-, second-, and third-order mesenteric arteries) of PVAT-denuded preparations. Confocal microscopy also showed that despite the removal of PVAT, there was an abundance of sensory nerves at the adventitia, consistent with previous evidence for a high density of CGRP-containing nerves on the surface of clean mesenteric arteries. 6, 8, 9, 32, 33 Exogenous CGRP produced similar responses in PVATþ and PVAT-preparations, indicating that the ability of the preparations to relax was unchanged. These observations highlight the importance of PVAT intactness in regulating vasodilatation, and support the possibility of interactions between sensory nerves at the adventitia with adipocytes, and/or continuity between adventitial sensory nerves and sensory nerves in PVAT as suggested for sympathetic nerves. 34 The contribution of PVAT to neurogenic vasorelaxation described here appears to be distinct from its known anticontractile effect, based on the different sensitivities of CGRP-mediated vasorelaxation and the anticontractile effect to blockade with potassium channel inhibitors.
35,36
The presence of sensory nerves within PVATof mesenteric arterial beds
Immunofluorescence staining of PVAT-denuded segments of rat superior mesenteric artery and second-order mesenteric arteries, showed the presence of extensive innervation with perivascular nerve fibres immunoreactive to anti-CGRP. Similar observations in mesenteric arterial preparations without PVAT have been reported previously. 6, 8, 9, 32, 33 CGRP-immunoreactivity was also visualized within PVAT in PVAT intact mesenteric arteries. A double staining protocol using anti-CGRP and anti-PGP 9.5 antibodies was applied, and co-localization of the staining was evident, which indicates the presence of sensory nerves within PVAT. Interestingly, neuronal somata were visualized in segments of both PVAT intact and PVAT denuded preparations. Traditionally, cell bodies of CGRP-containing nerves were believed to be located only in the dorsal root ganglia. However, there is evidence that adventitial neuronal somata containing mRNA encoding CGRP are present in rat small mesenteric arteries, 37 which is in line with the current observation. A more recent study revealed that the adventitial neuronal somata express a number of genes including paladin and CaSR which participate in response to injury/stress and vasodilatation. 38 Collectively these studies demonstrate that sensory neuronal somata may reside in the adventitia and PVAT of rat mesenteric arteries. CGRP release from dissected PVAT in the presence and absence of capsaicin, an agonist at vanilloid receptor subtype 1 (TRPV1), which releases CGRP from sensory nerves, was investigated using EIA. We found that the CGRP level in the supernatant of dissected PVAT, isolated from second-order mesenteric arteries, was significantly greater with capsaicin treatment than in the absence of capsaicin. CGRP levels in the physiological solution bathing dissected PVAT from superior mesenteric arteries were similar with and without capsaicin treatment. These observations suggest that sensory nerves are distributed in PVAT, and that the density of sensory nerves in PVAT is greater in resistance mesenteric arteries than in conduit mesenteric arteries, in line with our pharmacological studies. There is evidence that adipocytes from human abdominal fat express mRNA for CGRP, but CGRP protein expression was absent under control conditions and was only induced after treatment with LPS. 39 Thus, a source of CGRP within PVAT in cell types other than sensory nerves seems unlikely. 40 or sensitivity, or may involve the endothelium. 41 Leptin may also act pre-as well as post-junctionally. Leptin secreted from WAT was shown to act as a paracrine factor to increase the activity of spinal sensory nerves in WAT in Siberian hamsters. 25 More recently, leptin receptors were shown to be expressed on sensory neurons, and the deletion of leptin signalling in vagal afferent neurons resulted in hyperphagia and obesity. 42 PVAT-derived angiotensin II augmented sympathetic neurotransmission in rat mesenteric arteries, 43 but is unlikely to be involved here since it is a vasoconstrictor which inhibits CGRP release from sensory nerves in the rat mesenteric arterial bed. 7 Superoxide ions have been shown to promote sensory neurogenic relaxation in the rat isolated mesenteric arterial bed 44 and, since superoxide ions can be generated by rat mesenteric arterial PVAT (where they have been shown to enhance sympathetic neurotransmission), 45 this provides another mechanism by which sensory neurogenic relaxation may be augmented by PVAT. The present data add new insight into the crosstalk between leptin and sensory nerves. We investigated whether reduced tissue oxygenation, which can arise due to adipose tissue expansion, [46] [47] [48] can alter adipokine release, either with or without activation of sensory nerves. Under conditions of reduced oxygenation, levels of leptin and adiponectin in the mesenteric arterial bed perfusate were lower compared to control conditions, significantly so for adiponectin, and EFS failed to evoke a release of leptin. IL-6 levels were increased. Our data are consistent with pharmacological evidence for the generation of IL-6 in the PVAT of hypoxic (95% N 2 , 5% CO 2 for 2.5 h) rat isolated mesenteric arteries. 49 In our mesenteric arterial beds, methoxamine-induced tone was greatly attenuated in low oxygen conditions, likely through myogenic mechanisms as shown in rat hypoxic pre-constricted mesenteric arteries. 50 These data suggest that myogenic mechanisms may predominate over sensory neurogenic control to cause vasorelaxation and an increase in blood flow under conditions of reduced oxygenation. The data are consistent with the fact that vascular tone regulation is achieved by an interplay between factors including myogenic, neurogenic and PVAT influences, and that their relative impact and cross talk is influenced by the levels of tissue oxygenation. Communication between perivascular sympathetic nerves and the endothelium has also been demonstrated. 51 ,52
Limitations of the study
The mesenteric artery of rodents is surrounded by WAT, while human PVAT has characteristics of both WAT and BAT (brown adipose tissue). 21 With regard to leptin, plasma levels correlate positively with adipose tissue mass in both humans and rodents; leptin appears to operate mainly in the long-term control of feeding behaviour and energy balance, but may also function in short term control in rodents. 53 Various levels and durations of oxygenation have been used by others to investigate the effects of low oxygen on vascular function and in the present study the effects of gassing with atmospheric oxygen could additionally have been considered. Acute hypoxia, as used in the present study and by others, 49 can trigger an acute inflammatory reaction, as evidenced by the release of IL-6, and it should be noted that this is different to low-grade inflammation associated with adipose tissue hypoxia in obesity. 54, 55 Nonetheless, the in vitro effects reported here may be qualitatively similar to those observed in vivo.
Conclusions
This study has provided evidence that sensory nerves are expressed within the PVAT of rat mesenteric arteries and enhance neurogenic vasodilatation in rat isolated mesenteric arterial beds and mesenteric arteries. Interactions between sensory nerves within PVAT and adipocytes have also been revealed, since leptin release was enhanced by EFS of sensory nerves only in mesenteric arterial bed preparations with intact PVAT, and exogenous leptin augmented CGRP-induced relaxations. The present study also indicates that a low oxygen level reduces adiponectin and leptin levels measured in mesenteric arterial beds with PVAT, but enhances levels of IL-6. Collectively, these data indicate the presence of sensory nerves within PVAT, which play an integral role in vasocontractility and regulate PVAT-derived leptin release. The expression and role of sensory nerves in the cardiovascular system is potentially far greater than previously recognized since traditionally neurogenic control of isolated blood vessels has been investigated in preparations from which the PVAT has been removed, and this could be very relevant to the pathophysiology of diseases of the cardiovascular system including hypertension and obesity.
